XML 77 R50.htm IDEA: XBRL DOCUMENT v3.24.0.1
Acquisitions and Divestitures - Summary of Acquisition (Zymergen) (Details) - USD ($)
$ / shares in Units, shares in Thousands, $ in Thousands
12 Months Ended
Oct. 19, 2022
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
Business Acquisition [Line Items]        
Less: Cash severance and retention bonuses incurred for the benefit of the combined company     $ 11,100  
Total consideration   $ 0 $ 19,912 $ 8,760
Commo stock, issued (in shares)   2,138,993 2,031,884  
Common Class A        
Business Acquisition [Line Items]        
Commo stock, issued (in shares)   1,639,885 1,448,235  
Zymergen        
Business Acquisition [Line Items]        
Fair value of Class A common stock issued to Zymergen shareholders $ 236,331      
Fair value of replacement Ginkgo RSUs and Ginkgo Class A common stock issued under Zymergen RIFs attributable to pre-combination services 1,571      
Less: Cash severance and retention bonuses incurred for the benefit of the combined company (6,152)      
Total consideration $ 231,750      
Commo stock, issued (in shares) 96,900      
Zymergen | Common Class A        
Business Acquisition [Line Items]        
Commo stock, issued (in shares) 99,400      
Shares issued, price per share (in dollars per share) $ 2.44